{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T14:56:19Z","timestamp":1790175379368,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T00:00:00Z","timestamp":1721779200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Prevention of Alzheimer's Disease"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.14283\/jpad.2024.136","type":"journal-article","created":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T06:28:02Z","timestamp":1719469682000},"page":"874-880","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Pre-Randomization Predictors of Study Discontinuation in a Preclinical Alzheimer's Disease Randomized Controlled Trial"],"prefix":"10.1016","volume":"11","author":[{"given":"Rema","family":"Raman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Hussen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.C.","family":"Donohue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Ernstrom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.C.","family":"Holdridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Langford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.P.","family":"Molina-Henry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.L.","family":"Pierce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.R.","family":"Sims","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Yaari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.S.","family":"Aisen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Sperling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.D.","family":"Grill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.14283\/jpad.2024.136_bib1","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/s41582-022-00645-6","article-title":"Early-stage alzheimer disease: Getting trial-ready","volume":"18","author":"Aisen","year":"2022","journal-title":"Nat Rev Neurol"},{"issue":"Suppl2","key":"10.14283\/jpad.2024.136_bib2","doi-asserted-by":"crossref","first-page":"705","DOI":"10.18865\/ed.30.S2.705","article-title":"Together we make the difference: National strategy for recruitment and participation in alzheimer's and related dementias clinical research","volume":"30","author":"Elliott","year":"2020","journal-title":"Ethn Dis"},{"issue":"11","key":"10.14283\/jpad.2024.136_bib3","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.jalz.2016.10.001","article-title":"The crisis in recruitment for clinical trials in alzheimer's and dementia: An action plan for solutions","volume":"12","author":"Fargo","year":"2016","journal-title":"Alzheimers Dement"},{"issue":"2","key":"10.14283\/jpad.2024.136_bib4","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1002\/alz.12737","article-title":"Recommendations to address key recruitment challenges of alzheimer's disease clinical trials","volume":"19","author":"Langbaum","year":"2023","journal-title":"Alzheimers Dement"},{"issue":"4","key":"10.14283\/jpad.2024.136_bib5","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1377\/hlthaff.2013.1314","article-title":"Obstacles and opportunities in alzheimer's clinical trial recruitment","volume":"33","author":"Watson","year":"2014","journal-title":"Health Aff (Millwood)"},{"issue":"7","key":"10.14283\/jpad.2024.136_bib6","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.14606","article-title":"Inclusion of underrepresented groups in preclinical alzheimer disease trials-opportunities abound","volume":"4","author":"Manly","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"3","key":"10.14283\/jpad.2024.136_bib7","doi-asserted-by":"crossref","first-page":"388","DOI":"10.14283\/jpad.2022.50","article-title":"Tackling a major deficiency of diversity in alzheimer's disease therapeutic trials: An CTAD task force report","volume":"9","author":"Raman","year":"2022","journal-title":"J Prev Alzheimers Dis"},{"issue":"3","key":"10.14283\/jpad.2024.136_bib8","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1001\/jama.288.3.358","article-title":"The continuing unethical conduct of underpowered clinical trials","volume":"288","author":"Halpern","year":"2002","journal-title":"JAMA"},{"issue":"4","key":"10.14283\/jpad.2024.136_bib9","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/WAD.0000000000000353","article-title":"Retention of alzheimer disease research participants","volume":"33","author":"Grill","year":"2019","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.14283\/jpad.2024.136_bib10","author":"National Research Council"},{"issue":"2","key":"10.14283\/jpad.2024.136_bib11","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1177\/1740774520982315","article-title":"Research attitudes questionnaire scores predict alzheimer's disease clinical trial dropout","volume":"18","author":"Stites","year":"2021","journal-title":"Clin. Trials"},{"issue":"18","key":"10.14283\/jpad.2024.136_bib12","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1212\/WNL.0b013e3181bd6c25","article-title":"Donepezil treatment of patients with MCI: A 48-week randomized, placebo- controlled trial","volume":"73","author":"Crane","year":"2009","journal-title":"Neurology"},{"issue":"3","key":"10.14283\/jpad.2024.136_bib13","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1212\/WNL.0b013e31827debfe","article-title":"Effect of study partner on the conduct of alzheimer disease clinical trials","volume":"80","author":"Grill","year":"2013","journal-title":"Neurology"},{"issue":"1","key":"10.14283\/jpad.2024.136_bib14","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/nrneurol.2012.241","article-title":"Preclinical alzheimer disease-the challenges ahead","volume":"9","author":"Sperling","year":"2013","journal-title":"Nat. Rev. Neurol"},{"issue":"2","key":"10.14283\/jpad.2024.136_bib15","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jalz.2017.10.009","article-title":"Forecasting the prevalence of preclinical and clinical alzheimer's disease in the united states","volume":"14","author":"Brookmeyer","year":"2018","journal-title":"Alzheimers Dement"},{"issue":"228","key":"10.14283\/jpad.2024.136_bib16","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3007941","article-title":"The A4 study: Stopping AD before symptoms begin?","volume":"6","author":"Sperling","year":"2014","journal-title":"Sci. Transl. Med"},{"issue":"6","key":"10.14283\/jpad.2024.136_bib17","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1001\/jamaneurol.2020.0387","article-title":"Association of factors with elevated amyloid burden in clinically normal older individuals","volume":"77","author":"Sperling","year":"2020","journal-title":"JAMA Neurol"},{"issue":"12","key":"10.14283\/jpad.2024.136_bib18","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1056\/NEJMoa2305032","article-title":"Trial of solanezumab in preclinical alzheimer's disease","volume":"389","author":"Sperling","year":"2023","journal-title":"N. Engl. J. Med"},{"issue":"4","key":"10.14283\/jpad.2024.136_bib19","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/01.wad.0000213879.55547.57","article-title":"ADCS prevention instrument project: The mail-in cognitive function screening instrument (MCFSI)","volume":"20","author":"Walsh","year":"2006","journal-title":"Alzheimer Dis. Assoc. Disord"},{"issue":"4","key":"10.14283\/jpad.2024.136_bib20","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1001\/jamaneurol.2014.3375","article-title":"Tracking early decline in cognitive function in older individuals at risk for alzheimer disease dementia: The alzheimer's disease cooperative study cognitive function instrument","volume":"72","author":"Amariglio","year":"2015","journal-title":"JAMA Neurol"},{"issue":"1","key":"10.14283\/jpad.2024.136_bib21","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1017\/S1041610291000480","article-title":"Proposed factor structure of the geriatric depression scale","volume":"3","author":"Sheikh","year":"1991","journal-title":"Int. Psychogeriatr"},{"issue":"3","key":"10.14283\/jpad.2024.136_bib22","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.2044-8260.1992.tb00997.x","article-title":"The development of a six-item short-form of the state scale of the spielberger state-trait anxiety inventory (STAI)","volume":"31","author":"Marteau","year":"1992","journal-title":"Br. J. Clin. Psychol"},{"issue":"8","key":"10.14283\/jpad.2024.136_bib23","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1001\/jamaneurol.2014.803","article-title":"The preclinical alzheimer cognitive composite: Measuring amyloid-related decline","volume":"71","author":"Donohue","year":"2014","journal-title":"JAMA Neurol"},{"issue":"12","key":"10.14283\/jpad.2024.136_bib24","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1001\/jamaneurol.2020.2734","article-title":"Short-term psychological outcomes of disclosing amyloid imaging results to research participants who do not have cognitive impairment","volume":"77","author":"Grill","year":"2020","journal-title":"JAMA Neurol"},{"key":"10.14283\/jpad.2024.136_bib25","series-title":"R: A language and environment for statistical computing","author":"R core team.","year":"2023"},{"issue":"1","key":"10.14283\/jpad.2024.136_bib27","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/s13195-023-01352-0","article-title":"Estimating attrition in mild-to-moderate alzheimer's disease and mild cognitive impairment clinical trials","volume":"15","author":"Ritchie","year":"2023","journal-title":"Alzheimers Res. Ther"},{"issue":"2","key":"10.14283\/jpad.2024.136_bib28","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/WAD.0b013e3181c9983f","article-title":"NIA-funded alzheimer centers are more efficient than commercial clinical recruitment sites for conducting secondary prevention trials of dementia","volume":"24","author":"Edland","year":"2010","journal-title":"Alzheimer Dis. Assoc. Disord"},{"issue":"Suppl. 9","key":"10.14283\/jpad.2024.136_bib29","article-title":"Identifying predictive factors of patient dropout in alzheimer's disease clinical trials","volume":"17","author":"Crimin Kea","year":"2021","journal-title":"Alzheimer's and Dementia"},{"issue":"1","key":"10.14283\/jpad.2024.136_bib30","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jalz.2013.11.008","article-title":"Adverse events and dropouts in alzheimer's disease studies: What can we learn?","volume":"11","author":"Henley","year":"2015","journal-title":"Alzheimers Dement"},{"issue":"6","key":"10.14283\/jpad.2024.136_bib26","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/alzrt58","article-title":"Addressing the challenges to successful recruitment and retention in alzheimer's disease clinical trials","volume":"2","author":"Grill","year":"2010","journal-title":"Alzheimers Res. Ther"}],"container-title":["The Journal of Prevention of Alzheimer's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580724000104?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580724000104?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T02:07:23Z","timestamp":1737338843000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2274580724000104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S2274580724000104"],"URL":"https:\/\/doi.org\/10.14283\/jpad.2024.136","relation":{},"ISSN":["2274-5807"],"issn-type":[{"value":"2274-5807","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pre-Randomization Predictors of Study Discontinuation in a Preclinical Alzheimer's Disease Randomized Controlled Trial","name":"articletitle","label":"Article Title"},{"value":"The Journal of Prevention of Alzheimer's Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.14283\/jpad.2024.136","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2024 THE AUTHORS. Published by Elsevier Masson SAS on behalf of SERDI Publisher. Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}]}}